505 — Asiamedic Cashflow Statement
0.000.00%
Last trade - 00:00- SG$20.33m
- SG$30.55m
- SG$35.22m
Annual cashflow statement for Asiamedic, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.715 | 2.19 | 1.03 | 0.642 | 1.43 |
| Depreciation | |||||
| Non-Cash Items | 0.628 | -1.21 | -0.277 | 0.072 | -0.62 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.826 | -0.785 | 0.589 | -0.701 | -0.313 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 3.44 | 1.23 | 3.41 | 2.48 | 3.88 |
| Capital Expenditures | -0.379 | -0.999 | -2.43 | -1.81 | -2.68 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.32 | -1.65 | -2.43 | 2.02 | -0.305 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.058 | -2.65 | -4.86 | 0.214 | -2.98 |
| Financing Cash Flow Items | -0.143 | -0.332 | -0.072 | 2.5 | -0.884 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.56 | -1.41 | -0.589 | 0.693 | -3.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.82 | -2.83 | -2.04 | 3.39 | -2.3 |